삼일제약

000520KOSPI의약품 제조업

39.8 / 100

Reference Date: 2026-04-13

Financial Score7.5 / 40

News Sentiment16.3 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Slightly down 2.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Samil Pharmaceutical, established in 1947, is a mid-sized pharmaceutical company specializing in ophthalmology, epilepsy, and digestive system drugs, with a business structure focused on original and generic drug development, production, and sales. In 2025, its consolidated sales reached 210.3 billion won, and it has secured domestic sales rights for NASH treatment 'Aramchol' and osteoarthritis treatment 'Lorecivivint', while also completing a global ophthalmology CMO plant in Vietnam.

Number of Employees

614people

Average Salary

67.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 14.804.0Point

PBR

1.56Industry Average 1.042.5Point

Higher than industry avg (caution)

ROE

-22.41Industry Average 4.420.0Point

Well below industry avg

Debt Ratio

39.90Industry Average 11.980.0Point

3.3x industry avg (risky)

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲3.8% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼9923.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -8.3% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 1Neutral 1Negative 0Average Sentiment Score 65

Neutral
[바이오스냅] 휴온스바이오파마, 보툴리눔 톡신 중국 초도물량 출하
휴온스바이오파마가 보툴리눔 톡신 중국 초도물량을 출하했다는 내용의 뉴스입니다.
Positive
삼일제약, 온 가족 안심 사용 ‘부루부루 쿨링시트’ 출시
삼일제약이 갑작스러운 발열이나 야외 활동 시 간편하게 열감을 내릴 수 있는 '부루부루 쿨링시트'를 출시했습니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (17%, downtrend)

Current 9,580Won52-week high 13,76052-week low 8,670

1-month return2.0Point

1m -2.74% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

7 totalPositive 0Neutral 7Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-03-27
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-26
Neutral정기주주총회결과2026-03-26
Neutral최대주주등소유주식변동신고서2026-03-25
Neutral사업보고서 (2025.12)2026-03-18